Free shipping on orders over $75 · Shop the coastal collection

Vimentin Recombinant Rabbit mAb (SDT-029-20) Drug Target Proteins and the residual kanamycin in

SKU: 73048289022

4.4
USD100.00 USD138.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

and the residual kanamycin in the sample competes with the conjugated antigen pre coated on the microporous strip for anti kanamycin antibodies

CXCR2 responds to low concentrations of IL-8 and is mainly related to chemotaxis and MMP-9 release

Species Human Synonyms rHuGRO-β/CXCL2

10(11): 1183-1192

There are now four LAG3-targeted therapies in the clinic with many more in preclinical development [PMID: 28258692]

Vimentin Recombinant Rabbit mAb (SDT-029-20) Drug Target Proteins and the residual kanamycin inProduct Specification Host Rabbit Antigen Vimentin Immunogen Synthetic Peptide Accession P08670 Clone Number SDT 029 20 Antibody Type Rabbit mAb Isotype IgG Application WB, IHC P, ICC, IF Reactivity Hu, Ms, Rt Predicted Reactivity Pr, Bv, Cz, Pg, Hm, Av Purification Protein A Research Area Neuroscience Concentration 1 mg ml Molecular Weight 56kDa Conjugation Unconjugated Physical Appearance Liquid Storage Buffer PBS, 40% Glycerol, 0. 05%BSA, 0. 03%

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products